Capital Research Global Investors Merck & Co., Inc. Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 2,041,955 shares of MRK stock, worth $200 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,041,955
Previous 2,041,274
0.03%
Holding current value
$200 Million
Previous $253 Million
8.24%
% of portfolio
0.05%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.5 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.43 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.8 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $248B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...